Active Ingredient(s): Fospropofol Disodium
FDA Approved: * December 12, 2008
Pharm Company: * EISAI MEDCL RES
Category: Intravenous (IV) Therapy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Lusedra Overview

Fospropofol (INN[3]), often used as the disodium salt (trade name Lusedra[4]) is an intravenous sedative-hypnotic agent. It is currently approved for use in sedation of adult patients undergoing diagnostic or therapeutic procedures such as endoscopy. Contents 1 Clinical applications 2 Clinical pharmacology 2.1 Mechanism of action 2.2 Pharmacodynamics 2.3 Pharmacokinetics 3 Controlled substance 4 References Clinical applications Several water-soluble ...

Read more Lusedra Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Lusedra Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fospropofol Disodium
  • Injection: 35mg/ml
  • Solution: 1050mg/30ml (35mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lusedra: (1 result)

Sorted by National Drug Code
  • 62856-350 Lusedra 35 mg/ml Intravenous Injection by Eisai, Inc

Other drugs which contain Fospropofol Disodium or a similar ingredient: (1 result)